Income Tax
Regeneron Pharmaceuticals Income Tax decreased by 47.8% to $104.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $96.30M to $104.00M. Over 4 years (FY 2021 to FY 2025), Income Tax shows a downward trend with a -12.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase relative to pre-tax income may signal a higher effective tax rate or changes in tax legislation, while a decrease may indicate tax benefits or lower jurisdictional rates.
Detailed definition
Represents the total provision for income taxes recognized by the company during the reporting period, including both cu...
Peer comparison
Highly dependent on the company's geographic footprint and tax planning strategies compared to peers.
income_tax_expenseHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $653.90M | $184.40M | $274.40M | $87.60M | $111.10M | $194.10M | $127.60M | $40.20M | $114.50M | $103.00M | $0.00 | -$21.30M | $195.80M | $152.40M | $40.40M | $96.30M | $127.10M | $303.30M | $199.10M | $104.00M |
| QoQ Change | — | -71.8% | +48.8% | -68.1% | +26.8% | +74.7% | -34.3% | -68.5% | +184.8% | -10.0% | -100.0% | — | >999% | -22.2% | -73.5% | +138.4% | +32.0% | +138.6% | -34.4% | -47.8% |
| YoY Change | — | — | — | — | -83.0% | +5.3% | -53.5% | -54.1% | +3.1% | -46.9% | -100.0% | -153.0% | +71.0% | +48.0% | — | +552.1% | -35.1% | +99.0% | +392.8% | +8.0% |
Income Tax at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's income tax?
- Regeneron Pharmaceuticals (REGN) reported income tax of $104.00M in Q1 2026.
- How has Regeneron Pharmaceuticals's income tax changed year-over-year?
- Regeneron Pharmaceuticals's income tax increased by 8.0% year-over-year, from $96.30M to $104.00M.
- What is the long-term trend for Regeneron Pharmaceuticals's income tax?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's income tax has grown at a -12.7% compound annual growth rate (CAGR), from $1.25B to $725.80M.
- What does income tax mean?
- The total amount of income tax the company is required to pay on its earnings.